Cancer patients and targeted therapy during COVID‐19 pandemic: A descriptive case series study

Cancer patients and targeted therapy during COVID‐19 pandemic: A descriptive case series study

To evaluate the effectiveness of targeted therapy on preventing or treating COVID‐19, in this study, we want to share our experience about 14 patients (nine women, five men; average age, 59 years) who were treated with targeted therapy due to their underlying malignant disorders in our center. Targe...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical Case Reports 2022-10, Vol.10 (10), p.e6392-n/a
Hauptverfasser: Khodadadi, Kasra, Moghimi, Minoosh, Mansouri, Reza
Format: Artikel
Sprache:eng
Schlagworte:
Cancer
Cancer patients
Cancer therapies
Care and treatment
Case Report
Case reports
case series
Chemotherapy
Coronaviruses
COVID-19
Cytokines
Disease
Drugs
Enzymes
Health aspects
Hematology
Immunotherapy
Infections
Ipilimumab
Ligands
Lung cancer
malignant disease
Melanoma
Metastasis
Oncology, Experimental
Patients
Performance evaluation
Severe acute respiratory syndrome coronavirus 2
targeted therapy
Viral infections
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:To evaluate the effectiveness of targeted therapy on preventing or treating COVID‐19, in this study, we want to share our experience about 14 patients (nine women, five men; average age, 59 years) who were treated with targeted therapy due to their underlying malignant disorders in our center. Targeted therapy in COVID‐19 pandemic.
ISSN:2050-0904
2050-0904
DOI:10.1002/ccr3.6392